All In MedTech

Device Trial Radar · NCT05380960

Blood Hpercoagublity in Copd

A Study on the State of Coagulability in Patients With Chronic Obstructive Disease Admitted to Assiut University Hospital

Last checked: Nov 19, 2026Latest source record: May 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

120

Planned (sponsor's estimate)

Start

Jun 1, 2022

Primary completion

Sep 1, 2023

Study completion Dec 1, 2023

Sponsor

Lead sponsor
Assiut UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 19, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

"The objective of this study is to evaluate the blood coagulability state in patients with COPD admitted at Assiut University Hospital"

Conditions

  • Blood Coagulability in Copd

Interventions

  • cbc coaglation profileDevice

    The Demographic, clinical, and laboratory data for the enrolled subjects will be collected. To assess the coagulability state in the participants, we will measure the levels of certain markers in the blood that are thought to be associated with an increased coagulability. A comparison will be made between the different included groups regarding the level of these markers. These markers included complete blood count (CBC) indices (hematocrit, red cell distribution width, platelets count, mean platelet volume and platelet distribution width), C - reactive protein, d dimer, and blood coagulation tests (prothrombin time, international normalized ratio and partial thromboplastin time).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. "The objective of this study is to evaluate the blood coagulability state in patients with COPD admitted at Assiut University Hospital"Time frame: baseline

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.